Learn More
Description
Acts by plugging up the channels and limiting the entry of calcium into both smooth muscle cells of arteriolar walls and the cardiac muscle cells at higher doses.
- Blocks L-type Ca2+ channels in smooth and cardiac muscle
- Induces apoptosis of human primary and metastatic colon adenocarcinoma cells in vitro
- Drug resistance reversal agent acting on Pgp, e.g. decrease renal tubule elimination of digoxin
- Increases basal ATPase activity of Pgp
- Substrate of Cyp3A4 and CYP2C6
Specifications
Specifications
| Melting Point | 140°C to 150°C (literature) |
| Quantity | 1 g |
| Solubility Information | Soluble in water (7g/100mL); sparingly soluble in chloroform; soluble in ethanol (26mg/mL), isopropanol, acetone, ethyl acetate; freely soluble in methanol (>100mg/mL), DMF (>100mg/mL); practically insoluble in ether. |
| Formula Weight | 491.1 |
| Physical Form | Powder |
Safety and Handling
| Recommended Storage | Room Temperature (15–30°C) |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.